Clearmind Files Patent for Next-Gen Psychedelic Therapies
April 8, 2025
Clearmind Medicine Inc., a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced the publication